Chief investigator Professor Alan Burnett, from Cardiff Universitys School of Medicine, commented on the findings:
These promising results demonstrate how targeting a protein present in more than 90 per cent of AML patients can boost treatment without excessively increasing side effects.
Although there has been some controversy around the use of GO following its withdrawal in the US two years ago, these results appear extremely promising and suggest no such cause for concern if the appropriate dose is given. Crucially, this represents some of the first progress in treating AML patients of this age group for at least 20 years.
More top news
Leicester City's unlikely Premier League success features on the front pages of many of Tuesday's national newspapers.
Baywatch actor David Hasselhoff has got engaged to his Welsh girlfriend Hayley Roberts.
Leicester City players have been celebrating their Premier League title after Spurs drew with Chelsea on Monday night.